Example logo GIS 26

Global Innovation Summit 2026

6 May 2026 | Basel, Switzerland

Home
Register
Register
Register

Project cooperationUpdated on 9 April 2026

Portfolio Company Collaboration: Fina Biosolutions

Renaud Jacquemart

CEO at Omnium Global

Burlington, Canada

About

Our carrier protein portfolio includes GMP EcoCRM®(CRM197), Qb (virus-like particles), and Ready-to-Conjugate proteins. We are adding ClickCRM for site-specific click conjugation, and 8MTT, the first commercially available full-length genetically detoxified tetanus toxin. The FinaXpress E. coli expression system is used to make our carrier proteins and can be ideal for working with difficult-to-express proteins. The company has built on its conjugation expertise and now manufactures dextran-based reagents, which are used for flow cytometry, bead modification, and a myriad of other applications. We are interested in meeting with any companies with interest in carrier protein, expression system, or dextran conjugate products.

Stage

  • Execution
  • Planning

Topic

  • Biotech, Pharma and Cosmetics
  • Environment
  • Food, Beverages and Agriculture

Type

  • Research
  • Technical

Organisation

Omnium Global

SME

Toronto, Canada

Similar opportunities